SCIE期刊HIV Research & Clinical Practice 2024/2025影响因子:1.742 (HIV RES CLIN PRACT) (2578-7489). (PHARMACOLOGY & PHARMACY)(

显示全部楼层 · 发表于 2025-3-23 23:46:44

Submitted on: 28 September 2000. Revised on: 07 January 2001. Accepted on: 21 February 2001. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-24 05:47:04

Submitted on: 18 May 2017. Revised on: 11 June 2017. Accepted on: 29 July 2017. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-24 09:27:56

Submitted on: 19 December 2019. Revised on: 17 February 2020. Accepted on: 02 April 2020. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-24 14:37:53

显示全部楼层 · 发表于 2025-3-24 14:52:45

Submitted on: 08 January 2018. Revised on: 02 May 2018. Accepted on: 15 June 2018. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-24 21:59:12

Submitted on: 13 March 2009. Revised on: 18 May 2009. Accepted on: 13 June 2009. ___________________HIV Research & Clinical Practice

显示全部楼层 · 发表于 2025-3-25 02:28:29

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 08:20
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved